Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2000
05/25/2000WO2000029556A2 Identification of glycosphingolipids that promote hiv-1 entry into cells
05/25/2000WO2000029447A1 Rhamm antagonist antibodies
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same
05/25/2000WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000WO2000029443A1 Contraceptive antibody vaccines
05/25/2000WO2000029442A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029436A1 Protein amsh and cdna thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029434A2 PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
05/25/2000WO2000029432A1 Heliobacter pylori antigen
05/25/2000WO2000029431A1 Bispecific molecules cross-linking itim and itam for therapy
05/25/2000WO2000029430A1 Ring finger protein zapop3
05/25/2000WO2000029423A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029029A1 Compositions and methods for producing vascular occlusion
05/25/2000WO2000029020A1 Anti-icam-r antibody-induced apoptosis
05/25/2000WO2000029019A1 Restoration of platelet aggregation by antibody administration after gpiib/iiia antagonist treatment
05/25/2000WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase
05/25/2000WO2000029015A2 INFLUENCING OF ANGIGENESIS USING CD66a
05/25/2000WO2000029004A1 Small functional units of antibody heavy chain variable regions
05/25/2000WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
05/25/2000WO2000018428A3 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
05/25/2000WO2000015798A3 Mammalian transforming growth factor beta - 9 (ztgfss9)
05/25/2000WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000014227A8 Novel protein and dna thereof
05/25/2000WO2000007545A8 Apoptosis proteins
05/25/2000WO2000001410A9 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis
05/25/2000CA2351874A1 G protein-coupled receptor resembling the leukotriene b4 receptor
05/25/2000CA2351669A1 Small functional units of antibody heavy chain variable regions
05/25/2000CA2351585A1 Influencing of angigenesis using cd66a
05/25/2000CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
05/25/2000CA2351550A1 Phosphonate metabolizing plants
05/25/2000CA2351524A1 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumour vaccines
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2351313A1 Immunoglobulin superfamily proteins
05/25/2000CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same
05/25/2000CA2350917A1 Contraceptive antibody vaccines
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350623A1 Mammalian chondromodulin-like protein
05/25/2000CA2350603A1 Ring finger protein zapop3
05/25/2000CA2350415A1 Inflammation-associated genes
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2350389A1 Calcium binding protein
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000CA2350078A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
05/25/2000CA2349762A1 Human tslp dna and polypeptides
05/25/2000CA2349581A1 Anti-icam-r antibody-induced apoptosis
05/25/2000CA2348824A1 12 human secreted proteins
05/25/2000CA2348781A1 Compositions and methods for producing vascular occlusion
05/25/2000CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000CA2340468A1 Methods of facilitating vascular growth
05/24/2000EP1002864A1 HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
05/24/2000EP1002862A1 Methods of diagnosing or treating neurological diseases
05/24/2000EP1002861A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility
05/24/2000EP1002132A1 90 human secreted proteins
05/24/2000EP1002112A1 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
05/24/2000EP1002104A1 Novel metalloprotease
05/24/2000EP1002099A1 Synaptojanin isoform
05/24/2000EP1002093A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
05/24/2000EP1002092A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
05/24/2000EP1002090A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
05/24/2000EP1002084A1 Mammalian cytokine: interleukin-b30 and related reagents
05/24/2000EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene
05/24/2000EP1002077A1 Secreted proteins encoded by human chromosome 13
05/24/2000EP1002076A1 Proteins mediating switch recombination
05/24/2000EP1002075A1 Adipocyte-specific protein homologs
05/24/2000EP1002074A1 Calcium-binding phosphoprotein
05/24/2000EP1002073A2 Cell activation process and reagents therefor
05/24/2000EP1002070A1 Human atp-binding cassette transport protein
05/24/2000EP1002058A1 Isolation and identification of novel polymerases
05/24/2000EP1001991A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN
05/24/2000EP1001990A1 Protein that binds trail
05/24/2000EP1001987A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
05/24/2000EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
05/24/2000EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS
05/24/2000EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS
05/24/2000EP1001982A1 Cardiotrophin-like cytokine
05/24/2000EP1001981A1 Heregulin-like factor
05/24/2000EP1001964A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
05/24/2000EP1001815A1 Vectors derived from antibodies for transferring substances into cells
05/24/2000EP1001810A1 Pharmaceutical composition with neurotrophic-like biological activity
05/24/2000EP1001809A1 Decreased fat absorption with an anti-lipase antibody
05/24/2000EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
05/24/2000EP0804070B1 Process of isolation of proteins from milk
05/24/2000EP0497911B1 Recombinant production of lactoperoxidase
05/24/2000CN1254381A Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
05/24/2000CN1254377A Mammalian CHKL effector cell-cycle checkpoint protein kinase materials and methods
05/24/2000CN1254376A 端粒酶逆转录酶 Telomerase reverse transcriptase
05/24/2000CN1254375A Motilin homologs
05/24/2000CN1254294A Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
05/24/2000CN1254291A Use of leptin antagonists for treatment of diabetes
05/24/2000CN1254290A Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
05/24/2000CN1052733C Immuno-stimulatory monoclonal antibodies
05/23/2000USRE36713 APC gene and nucleic acid probes derived therefrom
05/23/2000US6066783 Genes encoding insecticidal proteins